기관회원 [로그인]
소속기관에서 받은 아이디, 비밀번호를 입력해 주세요.
개인회원 [로그인]

비회원 구매시 입력하신 핸드폰번호를 입력해 주세요.
본인 인증 후 구매내역을 확인하실 수 있습니다.

회원가입
서지반출
고삼(苦蔘)에탄올 추출물이 $NF{kappa}B$ 및 JNK, p38 조절을 통한 알레르기성 염증에 미치는 영향
[STEP1]서지반출 형식 선택
파일형식
@
서지도구
SNS
기타
[STEP2]서지반출 정보 선택
  • 제목
  • URL
돌아가기
확인
취소
  • 고삼(苦蔘)에탄올 추출물이 $NF{kappa}B$ 및 JNK, p38 조절을 통한 알레르기성 염증에 미치는 영향
저자명
이지영,박성식,Lee. Ji-Young,Park. Seong-Sik
간행물명
사상체질의학회지
권/호정보
2009년|21권 1호|pp.139-149 (11 pages)
발행정보
사상체질의학회
파일정보
정기간행물|
PDF텍스트
주제분야
기타
이 논문은 한국과학기술정보연구원과 논문 연계를 통해 무료로 제공되는 원문입니다.
서지반출

기타언어초록

1. Objectives The roots of Sophora flavescens Aiton (SFA) are widely used as a herbal remedy for allergic inflammation. In this study, we invested the effect of SFA on passive cutaneous anaphylaxis reaction and histamin releas and we demonstrated that SFA suppressed the production of pro-inflammatory cytokines, such as tumor necrosis factor-${alpha}$ (TNF-${alpha}$), interleukin- 6 (IL-6), and interleukin -8 (IL-8), through inhibition of the $NF{kappa}B$, JNK and p38 pathway in the human mast cell line, HMC-1. 2. Methods To accomplish this, we invested passive cutaneous anaphylaxis reaction and histamin release at an animal experiment. In addition, we investigated the effect of SFA on the production of inflammation-related cytokines in HMC-1 cells that were co-treated with PMA and A23187, which can induce production of pro-inflammatory cytokines. 3. Results and Conclusions SFA induced passive cutaneous anaphylaxis reaction and histamin releas and supressed the expression of TNF-${alpha}$, IL-6, and IL-8. In addition, the protein levels of TNF-${alpha}$ were also decreased by SFA treatment. Furthermore, SFA inhibited the nuclear translocation of nuclear factor $NF{kappa}B$ through inhibition of the phosphorylation and degradation of $I{kappa}B-{alpha}$, which is an inhibitor of $NF{kappa}B$. Moreover, SFA also inhibited induction of MAPKs (JNK, p38) and $NF{kappa}B$ promoter-mediated luciferase activity. Taken together, these results suggest that SFA could be used as a treatment for mast cell-derived allergic inflammatory diseases.